27 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
regarding the Company or its Subsidiaries or their financial results or prospects.
(nn) Cybersecurity. (i)(x) There has been no security breach
8-K
EX-10.1
h7s1 y6peiu2w625p3
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
424B5
nj3ezs j76ka3otoacio
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
8b7ecpq
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
7ng0pw4wq1
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
wmdmhz
7 Apr 22
Prospectus supplement
4:46pm
S-3
5ece8x4opri83o9
4 Feb 22
Shelf registration
4:36pm
10-K
9dokgf17nk5q
24 Sep 21
Annual report
7:31am
424B3
hyo5a6i71axm
22 Jul 21
Prospectus supplement
10:27am
424B3
xwfussnz
16 Mar 21
Prospectus supplement
12:00am
10-Q
5l8wphb2mdivzrr09as
17 Dec 20
Quarterly report
12:00am
424B4
xwnif9ztvd801
13 Nov 20
Prospectus supplement with pricing info
8:52pm